MYCN and neuroblastoma: Together, these results demonstrate that restoration of CTNNA2 expression is an advantageous strategy for in vivo neuroblastoma growth inhibition and tumor angiogenesis suppression in non-MYCN-amplified tumors, but less effective in MYCN-amplified tumors.